Caldera Health has expanded its commercial team with the appointment of Jennifer (Jen) Barnes as the head of Business Development to drive commercialisation of their prostate cancer biomarker assays. Jen is an experienced molecular diagnostics specialist, with over 15 years of experience in the clinical diagnostics field. She spent 12 years with Roche Diagnostics New Zealand, the last 6 as the Manager of Molecular and Tissue Diagnostics. She has also gained experience in health commercialisation as a business development manager at Auckland UniServices LTD, and is a co-founder in an early stage DNA biosensor company, Spot Check Technologies Ltd. Jen is a trained molecular biologist who started her career in research and clinical diagnostics. Her experience in both the science and commercial realms means she is adept at providing expert advice to support the commercialisation of life science and diagnostic opportunities.